Ilex Capital discloses 5.4% Canada Goose (GOOS) holding
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Ilex Capital Partners (UK) LLP has filed a Schedule 13G reporting beneficial ownership of 2,501,177 subordinate voting shares of Canada Goose Holdings Inc., representing 5.4% of the class as of the event date.
Ilex reports sole power to vote and dispose of all 2,501,177 shares, with no shared voting or dispositive power. The firm is organized in the United Kingdom and is authorized and regulated as an Alternative Investment Fund Manager by the UK Financial Conduct Authority.
Positive
- None.
Negative
- None.
FAQ
What percentage of Canada Goose (GOOS) does Ilex Capital Partners own?
Ilex Capital Partners (UK) LLP reports beneficial ownership of 5.4% of Canada Goose’s subordinate voting shares. This stake equals 2,501,177 shares, giving Ilex sole voting and dispositive power over this block according to the Schedule 13G filing.
What type of filing did Ilex Capital make regarding Canada Goose (GOOS)?
Ilex Capital Partners (UK) LLP filed a Schedule 13G regarding its holdings in Canada Goose. A Schedule 13G is typically used by certain institutional or passive investors to report beneficial ownership above 5% without pursuing an activist or control-related intent.
Where is Ilex Capital Partners based and how is it regulated?
Ilex Capital Partners (UK) LLP lists its principal office at The Kensington Building, 1 Wrights Lane, London, W8 5RY, United Kingdom. The firm states it is authorised and regulated as an Alternative Investment Fund Manager by the UK Financial Conduct Authority.
What class of Canada Goose securities does Ilex Capital hold?
Ilex Capital’s reported holdings are in subordinate voting shares of Canada Goose Holdings Inc. The filing identifies these as the relevant class of securities, tied to CUSIP number 135086106, and all reported ownership percentages and share counts relate to this class.